普利制药(300630) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 reached ¥513,587,330.59, representing a 35.03% increase compared to the same period last year[4] - Net profit attributable to shareholders for the same period was ¥165,041,086.70, up 30.50% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥165,101,415.02, reflecting a significant increase of 51.76% compared to the previous year[4] - The company reported a 36.93% increase in net profit attributable to shareholders for the year-to-date period, totaling ¥390,176,301.10[4] - Net profit for the period was CNY 390,176,301.10, representing a 37% increase compared to CNY 284,946,031.60 in the previous year[39] - The total comprehensive income for the period reached ¥390,176,301.10, compared to ¥284,946,031.60 in the previous period, representing an increase of approximately 37%[43] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥4,455,245,679.97, marking a 45.79% increase from the end of the previous year[4] - Total assets reached CNY 4,455,245,679.97, an increase of 45.7% compared to CNY 3,055,999,316.62 last year[34] - The company's total liabilities increased by 85.92% to ¥315,651,181.00 due to short-term borrowing for working capital[9] - Total liabilities amounted to CNY 1,846,700,406.76, a significant increase from CNY 1,016,848,007.93 year-on-year[35] - Short-term borrowings increased to CNY 315,651,181.00, compared to CNY 169,773,525.00 in the same period last year[34] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥156,679,118.33, showing a 43.47% increase compared to the same period last year[4] - Cash inflow from operating activities totaled ¥1,417,676,860.54, up from ¥1,154,502,270.42, indicating a rise of about 22.8%[44] - Net cash flow from operating activities was ¥156,679,118.33, compared to ¥109,210,599.47, showing an increase of about 43.3%[47] - Cash inflow from financing activities amounted to ¥1,372,325,849.73, up from ¥920,352,893.97, representing an increase of approximately 49.2%[50] - The net cash flow from financing activities was ¥905,996,049.53, compared to ¥623,221,736.79, indicating a growth of about 45.3%[50] - The ending balance of cash and cash equivalents was ¥623,880,152.83, compared to ¥428,367,728.56 in the previous period, reflecting an increase of approximately 45.5%[50] Shareholder Information - The company's basic earnings per share for Q3 2021 was ¥0.37, an increase of 27.85% year-on-year[4] - Basic and diluted earnings per share both increased to ¥0.89 from ¥0.65, reflecting a growth of 36.9%[43] - As of September 30, 2021, the company had 1.13 million shares of restricted stock remaining after the first unlock period, which represents 0.1271% of the total share capital[25] Inventory and Expenses - Inventory levels rose significantly by 198.71% to ¥281,054,779.46, indicating increased production and R&D material requirements[9] - Research and development expenses increased to CNY 204,105,266.69, a rise of 23.3% from CNY 165,400,436.31 year-on-year[39] - Cash outflow for purchasing goods and services was ¥720,757,934.03, compared to ¥523,780,105.91 in the previous period, marking an increase of approximately 37.6%[47] Other Financial Metrics - The weighted average return on equity decreased by 6.92% to 7.22% in the current reporting period[4] - The company's fixed assets increased to RMB 701.34 million, up from RMB 536.60 million, reflecting a growth of 30.6%[29] - Non-current assets totaled CNY 2,583,421,577.53, up 42% from CNY 1,823,214,597.62 in the previous year[34] - The company issued 8.5 million convertible bonds in February 2021, with a conversion price adjusted to RMB 46.03 per share effective from July 9, 2021[22] - The company plans to implement a second employee stock ownership plan, which has been approved and is currently in progress[23] - The company reported a significant increase in prepayments, which rose to RMB 61.04 million from RMB 37.06 million, marking a growth of 64.8%[29] - The company’s investment properties decreased slightly to RMB 24.64 million from RMB 26.21 million, indicating a decline of 6%[29] Audit Information - The company did not undergo an audit for the third quarter report[51]